Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 382 (RNA5SP382) is a human pseudogene originating from duplication or mutation of the 5S ribosomal RNA gene. Unlike the functional 5S rRNA, which is a crucial structural and functional component of the large ribosomal subunit involved in protein synthesis, RNA5SP382 does not encode a protein and is not known to participate directly in ribosome assembly, signal transduction, or other cellular processes. Pseudogenes such as RNA5SP382 are generally considered non-functional but may sometimes exert regulatory effects at the RNA level, such as acting as competing endogenous RNAs or influencing epigenetic regulation, although such roles have not been characterized for this particular gene. RNA5SP382 is not considered a therapeutic target, and there are no reported diseases, interacting drugs, or safety concerns associated with this pseudogene.
Not applicable. No therapeutic agents target this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 382 (RNA5SP382).